Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Feb 27, 2024 1:25pm
101 Views
Post# 35901847

RE:RE:RE:RE:RE:RE:RE:RE:Very strange , even for ONC

RE:RE:RE:RE:RE:RE:RE:RE:Very strange , even for ONC
That is an awfully long post to not say you were wrong and all I did was provide the correct information. You can take it how you want.
Also your quote about matt's options and there was no discalimer from what I saw.

Considering Matt exercised his 350,000 options. Is clear evidence the roof is not falling in.
Regardless now that the cat is out of the bag. There will be news to follow.
Could be great, bad or insignificant.

You also said
What I do know 100% factual; they are over a week late for year end " notice".

that is not even close to being 100% factual




and then you said

I know companies must submit reports publicly, I'm not sure if they need to give advance notice.
either way, they are a week late.
Never happened in the 20+ years.

Again 100% wrong.

This is not creating fud as you say, all I am doing is providing factual information with direct quotes and that is 100% factual.


And then you go on to say.....

Respectfully if Onc fails. Matt not only looses his job, but his whole life savings. Onc does not have an employee pension plan.

Yes Matt would be out of a job but HOW would he lose his whole life savings and do you need an employee pension plan when you get your rrsp and tfsa topped up to the Max and make more in a couple years than most make in a lifetime...Let's at least be realistic, Matt and all the exec would be just fine



And you still can"t admit that you made a mistake and mislead people.
<< Previous
Bullboard Posts
Next >>